Skip to main navigation Skip to search Skip to main content

A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine

  • The International Headache Genetics Consortium
  • , The 23andMe Research Team
  • Brigham and Women’s Hospital
  • Harvard University
  • Massachusetts General Hospital
  • Broad Institute
  • Wellcome Trust Sanger Institute
  • University of Oslo
  • University of Helsinki
  • University of Tartu
  • Boston Children's Hospital
  • Statens Serum Institut
  • University of Copenhagen
  • Illumina, Inc.
  • Vall d'Hebron Research Institute
  • Folkhalsan
  • 23andMe Inc.
  • Charité – Universitätsmedizin Berlin
  • Université de Bordeaux
  • deCODE Genetics
  • University of Bristol
  • Vrije Universiteit Amsterdam
  • Leiden University
  • Helsinki University Hospital
  • Ludwig Maximilian University of Munich
  • University of Tübingen
  • Karolinska Institutet
  • Queensland Institute of Medical Research
  • Ulm University
  • University of Oulu
  • King's College London
  • Erasmus University Rotterdam
  • Fimlab Laboratories
  • University of Duisburg-Essen
  • Landspitali University Hospital
  • VU University Medical Center
  • Washington University St. Louis
  • University of Groningen
  • University of Oxford
  • John Radcliffe Hospital
  • Max Planck Institute of Psychiatry
  • Kiel University
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • National Institute for Health and Welfare
  • Norwegian Institute of Public Health
  • Kiel Pain and Headache Center
  • MHC Sct. Hans
  • H. Lundbeck A/S
  • University of Turku
  • Imperial College London
  • University of Hamburg
  • St. George's University of London
  • Munich Cluster for Systems Neurology (SyNergy)
  • University of Iceland
  • Queensland University of Technology

Research output: Contribution to journalArticlepeer-review

Abstract

Blood pressure (BP) was inconsistently associated with migraine and the mechanisms of BP-lowering medications in migraine prophylaxis are unknown. Leveraging large-scale summary statistics for migraine (Ncases/Ncontrols = 59,674/316,078) and BP (N = 757,601), we find positive genetic correlations of migraine with diastolic BP (DBP, rg = 0.11, P = 3.56 × 10−06) and systolic BP (SBP, rg = 0.06, P = 0.01), but not pulse pressure (PP, rg = −0.01, P = 0.75). Cross-trait meta-analysis reveals 14 shared loci (P ≤ 5 × 10−08), nine of which replicate (P < 0.05) in the UK Biobank. Five shared loci (ITGB5, SMG6, ADRA2B, ANKDD1B, and KIAA0040) are reinforced in gene-level analysis and highlight potential mechanisms involving vascular development, endothelial function and calcium homeostasis. Mendelian randomization reveals stronger instrumental estimates of DBP (OR [95% CI] = 1.20 [1.15–1.25]/10 mmHg; P = 5.57 × 10−25) on migraine than SBP (1.05 [1.03–1.07]/10 mmHg; P = 2.60 × 10−07) and a corresponding opposite effect for PP (0.92 [0.88–0.95]/10 mmHg; P = 3.65 × 10−07). These findings support a critical role of DBP in migraine susceptibility and shared biology underlying BP and migraine.

Original languageEnglish
Article number3368
JournalNature Communications
Volume11
Issue number1
DOIs
Publication statusPublished - 1 Dec 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine'. Together they form a unique fingerprint.

Cite this